eFFECTOR Therapeutics, Inc. Warrant

EFTRW

Valor de mercado US$ 2,34 mil

Sobre: eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

Funcionários: 14